School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Universal Scientific Education and Research Network (USERN), Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Tehran, Iran.
Immun Inflamm Dis. 2023 Apr;11(4):e833. doi: 10.1002/iid3.833.
Inborn errors of immunity (IEI) comprise a group of about 490 genetic disorders that lead to aberrant functioning or the development of distinct immune system components. So far, a broad spectrum of IEI-related manifestations has been noted in the literature. Due to overlapping signs and symptoms of IEI, physicians face challenges in appropriately diagnosing and managing affected individuals. The last decade has witnesses improving in the molecular diagnosis of IEI patients. As a result, it can be the mainstay of diagnostic algorithms, prognosis, and possibly therapeutic interventions in patients with IEI. Furthermore, reviewing IEI clinical complications demonstrates that the manifestations and severity of the symptoms depend on the involved gene that causes the disease and its penetrance. Although several diagnostic criteria have been used for IEI, not every patient can be explored in the same way. As a result of the failure to consider IEI diagnosis and the variety of diagnostic capabilities and laboratory facilities in different regions, undiagnosed patients are increasing. On the other hand, early diagnosis is an almost essential element in improving the quality of life in IEI patients. Since there is no appropriate guideline for IEI diagnosis in different organs, focusing on the clues in the patient's chief complaint and physical exams can help physicians narrow their differential diagnosis. This article aims to provide a practical guide for IEI diagnosis based on the involved organ. We hope to assist clinicians in keeping IEI diagnosis in mind and minimizing possible related complications due to delayed diagnosis.
先天性免疫缺陷(IEI)包括约 490 种遗传疾病,这些疾病导致免疫系统成分的功能异常或发育异常。到目前为止,文献中已经注意到了广泛的 IEI 相关表现。由于 IEI 的体征和症状重叠,医生在适当诊断和管理受影响的个体方面面临挑战。过去十年见证了 IEI 患者分子诊断的改善。因此,它可以成为 IEI 患者诊断算法、预后和可能治疗干预的主要依据。此外,回顾 IEI 的临床并发症表明,症状的表现和严重程度取决于导致疾病的相关基因及其外显率。尽管已经使用了几种诊断标准来诊断 IEI,但并非每个患者都可以采用相同的方式进行探索。由于未能考虑 IEI 诊断以及不同地区诊断能力和实验室设施的多样性,未确诊的患者正在增加。另一方面,早期诊断是改善 IEI 患者生活质量的几乎必要因素。由于不同器官的 IEI 诊断没有适当的指南,因此关注患者主要诉求和体检中的线索可以帮助医生缩小鉴别诊断的范围。本文旨在根据受累器官为 IEI 诊断提供实用指南。我们希望帮助临床医生牢记 IEI 诊断,并尽量减少因诊断延误而导致的可能相关并发症。